PT Medela Potentia Tbk (ISX:MDLA) EBIT: Rp553,428 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:MDLA PT Medela Potentia Tbk ISX:MDLA
13 GF Score
Price Rp208.00
! 2 Warning Signs
View Full Analysis

What is PT Medela Potentia Tbk EBIT?

PT Medela Potentia Tbk ISX:MDLA -0.95% 13 EBIT is Rp553,428 Mil as of Jun. 2026. GuruFocus rates ISX:MDLA with a GF Score™ of 13/100. The stock has 2 warning signs investors should review.

PT Medela Potentia Tbk's earnings before interest and taxes (EBIT) for the three months ended in Jun. 2026 was Rp137,630 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2026 was Rp553,428 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. PT Medela Potentia Tbk's annualized ROC % for the quarter that ended in Jun. 2026 was 14.40%. PT Medela Potentia Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 21.91%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. PT Medela Potentia Tbk's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 22.09%.

PT Medela Potentia Tbk  (ISX:MDLA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

PT Medela Potentia Tbk's annualized ROC % for the quarter that ended in Jun. 2026 is calculated as:

ROC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=524724 * ( 1 - 21.85% )/( (2761746 + 2934706)/ 2 )
=410071.806/2848226
=14.40 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6888950 - 3386177 - ( 741027 - max(0, 3572916 - 6266324+741027))
=2761746

Invested Capital(Q: Jun. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=6605424 - 3111566 - ( 559152 - max(0, 3368086 - 5996662+559152))
=2934706

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

PT Medela Potentia Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=550520/( ( (582573 + max(1858704, 0)) + (569135 + max(2014086, 0)) )/ 2 )
=550520/( ( 2441277 + 2583221 )/ 2 )
=550520/2512249
=21.91 %

where Working Capital is:

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2604734 + 2039575 + 752683) - (3386177 + 0 + 152111)
=1858704

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(2640027 + 1886084 + 817134) - (3111566 + 0 + 217593)
=2014086

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

PT Medela Potentia Tbk's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Jun. 2026 )
=553428/2505418.600
=22.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Medela Potentia Tbk EBIT Related Terms

PT Medela Potentia Tbk EBIT Historical Data

* Premium members only.

The historical data trend for PT Medela Potentia Tbk's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Medela Potentia Tbk EBIT Chart

PT Medela Potentia Tbk Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
432,080.00 416,667.00 416,871.00 473,648.00 525,308.00

PT Medela Potentia Tbk Quarterly Data
Dec21 Dec22 Dec23 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 118,183.00 122,355.00 136,486.00 156,957.00 137,630.00

ISX:MDLA vs MCK, COR, CAH: EBIT Comparison

For the Medical Distribution subindustry, PT Medela Potentia Tbk's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Medela Potentia Tbk EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PT Medela Potentia Tbk's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where PT Medela Potentia Tbk's EV-to-EBIT falls into.


ISX:MDLA
13GF Score
PT Medela Potentia Tbk ISX:MDLA
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Medela Potentia Tbk EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp553,428 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of Rp553,428 Mil mean?
PT Medela Potentia Tbk (ISX:MDLA) has a EBIT of Rp553,428 Mil as of Jun. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on PT Medela Potentia Tbk.
Is PT Medela Potentia Tbk's EBIT too high?
PT Medela Potentia Tbk's current EBIT is Rp553,428 Mil. Overall, PT Medela Potentia Tbk has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PT Medela Potentia Tbk's EBIT compare to MCK and COR?
PT Medela Potentia Tbk's EBIT of Rp553,428 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on PT Medela Potentia Tbk. PT Medela Potentia Tbk's current EBIT is Rp553,428 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medela Potentia Tbk stock overvalued right now?
PT Medela Potentia Tbk (ISX:MDLA) has a current EBIT of Rp553,428 Mil. The current EBIT is Rp553,428 Mil. PT Medela Potentia Tbk's overall GF Score™ is 13/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For PT Medela Potentia Tbk (ISX:MDLA), the current EBIT is Rp553,428 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT Medela Potentia Tbk Business Description

Address Jl. RS Fatmawati Kav. 33, Cilandak Barat, Jakarta Selatan, Jakarta, IDN, 12430
PT Medela Potentia Tbk is a healthcare-focused holding company engaged in pharmaceutical distribution, medical device manufacturing, and marketing services. It is engaged in the distribution and marketing of pharmaceutical products, health products, and medical devices. It also manufactures medical devices and implements web portals and digital platforms for commercial purposes through its subsidiaries. The Company manages three main operating segments, namely pharmaceutical products, healthcare products, and medical devices.
13GF Score

Get the complete analysis for ISX:MDLA

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp208.00
Price